Views & Analysis Why pharma companies need to upgrade their intelligence Pairing AI capabilities with human strengths can bring a competitive edge in this rapidly-changing world.
News GSK suffers a setback with its TIM-3 programme GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face